Skip to main content
The William Harvey Research Institute - Faculty of Medicine and Dentistry
  1. WHRI
  2. News and Events
  3. 2025

2025

Professor Sir Mark Caulfield Professor Sir Mark Caulfield elected member of the Medical Research Council
2 April 2025

Professor Caulfield, Professor of Clinical Pharmacology and Vice-Principal (Health) at Queen Mary, joins twelve other senior figures from health, science, and medicine on the Council.

Potential side effects of medicine, photo credit Cagkan on Adobe Stock. Testing patients for just three genes could help prevent three quarters of avoidable side effects of certain medications
28 March 2025

A new study from Queen Mary University of London found that 9% of all adverse drug reactions (ADRs) reported to the UK medicines regulator are associated with medications where side effect risk is partly dependent on patient’s genes. Of this subset of ADRs, 75% were associated with only three genes that impact how the body processes medication. Genetic testing before prescribing could therefore help avoid ADRs in these cases.

South African Hospital New study of critically ill patients in Africa finds that lives could be saved with improvements to hospitals’ emergency and critical care treatments
10 March 2025

An international study of acute hospitals across Africa found a large and neglected burden of critical illness, and a high incidence of preventable deaths due to issues with the provision of basic critical care. 

3d rendered medically accurate illustration of the adrenal gland. Photo credit: Sebastian Kaulitzki New adrenal stem cell marker may improve diagnosis and treatment of adrenal cancer
4 March 2025

A large international study led by researchers at Queen Mary University of London has identified a new biomarker that could support the diagnosis and treatment of adrenal cancer.

Child being measured From height to health: largest global genetic study reveals hidden risks and benefits linked to stature
3 March 2025

New genetic links have been discovered between genetically-predicted height and an individual’s likelihood of developing a range of diseases and conditions. These new data could help improve early diagnosis and risk monitoring for patients.

DNA Landmark study finds 69 previously unidentified genetic determinants of rare disease
27 February 2025

The breakthrough research led by Queen Mary University of London uses a new analytical approach for identifying the genetic basis of rare diseases, which could diagnose more cases and help develop new treatments for patients.

Gene Testing Almost 90% of people would agree to genetic testing to tailor medication use, survey finds
20 February 2025

  • New research shows almost 90% of people in England would agree to genetic testing to get the most effective medication and reduce the risk of side effects 
  • 85% thought that the NHS should offer pharmacogenomic testing to people with multiple health conditions 
  • 58% of people thought that the NHS should offer this testing to everyone 
  • 91% wanted access to their own pharmacogenomic data, with many wanting this via the NHS app 

Molecular Imaging of the Adrenal Glands in 3 Patients. New treatment offers quick cure for common cause of high blood pressure
10 February 2025

A revolutionary new treatment called Targeted Thermal Therapy (Triple T) offers a safer, faster alternative to surgery for patients with high blood pressure caused by Primary Aldosteronism, a hormonal disorder. 

Prof Steffen Petersen receiving the SCMR Gold Medal Award 2025 Professor Steffen Petersen awarded 2025 SCMR Gold Medal for excellence in cardiovascular medicine
3 February 2025

Steffen Petersen, Professor of Cardiovascular Medicine at Queen Mary University of London, has been honoured with the Society for Cardiovascular Magnetic Resonance (SCMR) Gold Medal Award. This prestigious recognition celebrates his outstanding contributions to the field of Cardiovascular Magnetic Resonance (CMR). Professor Petersen received the award on January 31, 2025, at the SCMR annual conference held in Washington, DC.

Queen Mary University of London is playing a key role in major new European research initiative to combat Multi-Drug Resistant Rheumatoid Arthritis (MDR-RA)
29 January 2025

The MDR-RA (Multi-Drug Resistance in Rheumatoid Arthritis) project, with a total budget of €8.4 million, is funded by the European Union under the Horizon Europe programme and the Swiss State Secretariat for Education, Research, and Innovation. 

Thyroid Illustration New study shows AI can improve thyroid cancer diagnosis with artificially created images
7 January 2025

Researchers at Queen Mary University of London have found a new way to improve the accuracy of thyroid cancer diagnoses using artificial intelligence (AI). The study used a special type of approach, called Generative Adversarial Networks (GANs), to create realistic images of thyroid tissue samples. These fake images were then used to train AI systems to better detect cancer pathologies in real-life samples, potentially leading to more accurate diagnoses.

Torso Doctors warn against fluid therapy approach in surgery after global trial
6 January 2025

A major study aiming to improve outcomes from higher risk operations has ruled out a fluid therapy approach during surgery.

Back to top